OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 26 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$12,427,000,000
-16.7%
7,500,000
-25.0%
0.20%
-19.4%
Q1 2017$14,919,000,00010,000,0000.25%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Mint Tower Capital Management B.V. 10,000,000$14,917,0003.39%
Opera Trading Capital 5,700,000$8,490,0002.38%
TFG Asset Management GP Ltd 8,100,000$12,093,0002.27%
CQS Cayman LP 18,000,000$26,872,0002.04%
BASSO CAPITAL MANAGEMENT, L.P. 6,470,000$9,632,0001.43%
Myriad Asset Management Ltd. 9,416,000$14,061,0001.04%
CAMDEN ASSET MANAGEMENT L P /CA 22,025,000$32,817,0000.85%
ANGELO GORDON & CO., L.P. 7,000,000$10,430,0000.64%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 25,000,000$37,301,0000.54%
CSS LLC/IL 5,105,000$7,617,0000.46%
View complete list of LIGAND PHARMACEUTICALS INC shareholders